OriGene Technologies Inc. Inks Antibody Sample Distribution Deal with One World Lab

Press Release • Apr 2, 2015

OriGene announced today it has signed an agreement with One World Lab to become a global distributor of OriGene's antibody portfolio that includes premium branded UltraMAB® monoclonal antibodies, internally developed and validated through OriGene's protein high density chips for mono specificity, as well as TrueMAB® monoclonal antibodies that are generated with full length protein antigens.

San Diego, California, April 2, 2015 (Newswire.com) - OriGene Technologies Inc. Inks Antibody Sample Distribution Deal with One World Lab

Apr 2, 2015

"The agreement will allow OriGene to expand our distribution channel and give customer more choices on antibody package size selection. With this collaboration, customers will have easy access to some of the highest quality antibodies in the market such as UltraMABs and TrueMABs."

Donghui Ma, Senior Vice President

OriGene today announced it has signed an agreement with One World Lab to become a global distributor of OriGene’s antibody portfolio.

Under the terms of the agreement, One World Lab will employ its sales, marketing, and e-commerce expertise, and relationships with the scientific community to present and distribute OriGene antibodies. This agreement covers OriGene’s premium branded UltraMAB® monoclonal antibodies, internally developed and validated through OriGene’s protein high density chips for mono specificity, as well as TrueMAB® monoclonal antibodies that are generated with full length protein antigens.

Financial details of the agreement were not disclosed.

"The addition of OriGene’s proprietary antibodies supports our strategy and broadens our portfolio to more than 75,000 unique antibodies. Researchers will have several thousand more antibodies to affordably sample, while knowing with confidence that each antibody is sourced from the original manufacturer and not re-labeled. OWL allows researchers to affordably evaluate multiple antibodies to each antigen, before committing to a full size vial. Now they can rank and score each antibody to determine which will be best for their assay. When they participate is the unbiased review section they earn significant discounts towards full size vials. Researchers are doing more validation experiments with smaller amounts, and this is accelerating the pace of discovery.” Mike Simson, CEO of One World Lab, said in a statement.

“The agreement will allow OriGene to expand our distribution channel and give customer more choices on antibody package size selection. With this collaboration, customers will have easy access to some of the highest quality antibodies in the market such as UltraMABs® and TrueMABs®.” added Donghui Ma, Senior Vice President of OriGene Technologies Inc. One World Lab will begin distribution of $50 sample-size and full-size OriGene Antibodies later this spring, the firm said in a statement.

For more information, visit http://www.origene.com or http://oneworldlab.com

To contact a company representative email: info@oneworldlab.com or call: 855-695-5227.

About One World Lab, Inc.

One World Lab, Inc. is the first company to exclusively partner with original manufacturers providing their unique products in a test size format to enable affordable testing under experimental condition. Its ultimate purpose is to crowd-source products used in the Life Sciences/Medical Research industry with its review section and provide an improved dialog between manufacturers and researchers.